Position in NVS
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$1,367,668,323
+$65,163,426 QoQ
Shares Held
8,726,827
+2.3% QoQ
Ownership
0.459%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
#2
of 1,603 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 52%
Shared 0%
None 48%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026MORGAN STANLEY holds $63,698,443,803 across 20 Drug Manufacturers - General names. NVS ranks #10 (2.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
16,226,398 | $19,462,430,163 | |
| 2 | JNJ |
Johnson & Johnson
|
44,808,254 | $11,379,952,259 | |
| 3 | ABBV |
AbbVie Inc.
|
38,901,001 | $9,789,047,884 | |
| 4 | MRK |
Merck & Co., Inc.
|
48,641,158 | $6,250,388,797 | |
| 5 | AMGN |
Amgen Inc
|
13,653,692 | $4,944,274,940 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
24,004,354 | $3,032,710,073 | |
| 7 | PFE |
Pfizer Inc
|
96,345,452 | $2,319,998,477 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
29,009,025 | $1,671,500,010 |
All Filings in NVS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,367,668,323 | 8,726,827 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $1,302,504,897 | 8,527,037 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $1,223,859,024 | 8,876,906 | Shares | Defined | 2026-05-27 | |
| 2025-09-30 | $991,150,668 | 7,728,873 | Shares | Defined | 2026-05-27 | |
| 2025-06-30 | $914,773,637 | 7,559,488 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $786,592,952 | 7,055,911 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $668,437,468 | 6,869,155 | Shares | Defined | 2025-05-15 | |
| 2024-09-30 | $803,399,972 | 6,984,872 | Shares | Defined | 2025-05-14 | |
| 2024-06-30 | $789,579,642 | 7,416,679 | Shares | Defined | 2025-05-14 | |
| 2024-03-31 | $702,103,188 | 7,258,381 | Shares | Defined | 2024-10-17 | |
| 2023-12-31 | $716,104,780 | 7,092,253 | Shares | Defined | 2024-08-16 | |
| 2023-09-30 | $710,762,064 | 6,977,833 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $733,154,638 | 7,265,431 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $608,530,872 | 6,614,466 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $588,609,137 | 6,488,196 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $464,459,328 | 6,110,503 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $540,889,377 | 6,398,786 | Shares | Defined | 2022-10-27 | |
| 2022-03-31 | $286,413,892 | 3,263,976 | Shares | Defined | 2022-10-27 | |
| 2021-12-31 | $304,714,775 | 3,483,649 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $263,002,760 | 3,215,979 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $270,066,838 | 2,959,961 | Shares | Defined | 2021-08-23 | |
| 2021-03-31 | $242,771,662 | 2,840,099 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $265,253,207 | 2,808,993 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $221,360,853 | 2,545,548 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $234,835,860 | 2,688,755 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $309,675,106 | 3,755,914 | Shares | Defined | 2020-05-26 | |
| No filing history on record for this holder in this stock. | ||||||